Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
small molecule |
| gptkbp:approvalYear |
2020
|
| gptkbp:approvedBy |
gptkb:Japan
|
| gptkbp:ATCCode |
D11AH07
|
| gptkbp:brand |
Corectim
|
| gptkbp:CASNumber |
1445572-50-9
|
| gptkbp:chemicalClass |
pyrrolopyrimidine derivative
|
| gptkbp:developedBy |
gptkb:Japan_Tobacco
|
| gptkbp:form |
gptkb:hospital
|
| gptkbp:hasMolecularFormula |
C22H24N6O2
|
| https://www.w3.org/2000/01/rdf-schema#label |
delgocitinib
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
Janus kinase inhibitor
|
| gptkbp:routeOfAdministration |
topical
|
| gptkbp:target |
gptkb:JAK2
gptkb:JAK1 gptkb:TYK2 gptkb:JAK3 |
| gptkbp:usedFor |
gptkb:atopic_dermatitis
|
| gptkbp:bfsParent |
gptkb:Janus_kinases
|
| gptkbp:bfsLayer |
8
|